Cargando…
ePS4.01 The impact of the SARS-CoV-2 pandemic on people with cystic fibrosis (CF) in Ireland: did individuals maintain their key health outcomes?
Autores principales: | Rees, H., Babu, S., Doherty, R., Fletcher, G., Joshy, S., O’Regan, P., Kirwan, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184768/ http://dx.doi.org/10.1016/S1569-1993(22)00309-5 |
Ejemplares similares
-
ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
por: Lausen, M., et al.
Publicado: (2022) -
ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022) -
P084 The impact of the SARS-CoV-2 pandemic on people living with cystic fibrosis in Ireland: real-world data from the Irish cystic fibrosis registry
por: Rees, H., et al.
Publicado: (2021) -
P4.01. Omega-3 Fatty Acids Throughout the Pediatric Lifecycle
por: McClafferty, Hilary
Publicado: (2013) -
ePS4.03 Outcomes of COVID-19 in patients with cystic fibrosis in Wales, UK
por: Lau, D., et al.
Publicado: (2022)